A Comparison of BTA Stat, Hemoglobin Dipstick, Telomerase and Vysis Urovysion Assays for the Detection of Urothelial Carcinoma in Urine-Reference-Cited by-同舟云学术

A Comparison of BTA Stat, Hemoglobin Dipstick, Telomerase and Vysis Urovysion Assays for the Detection of Urothelial Carcinoma in Urine

Published:2002-05 Issue:5 Volume:167 Page:2001-2006
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

HALLING KEVIN C.¹,KING WALTER¹,SOKOLOVA IRINA A.¹,KARNES R. JEFFREY¹,MEYER REID G.¹,POWELL ERIC L.¹,SEBO THOMAS J.¹,CHEVILLE JOHN C.¹,CLAYTON AMY C.¹,KRAJNIK KELLY L.¹,EBERT THOMAS A.¹,NELSON ROBERT E.¹,BURKHARDT HALEH M.¹,RAMAKUMAR SANJAY¹,STEWART CHRISTOPHER S.¹,PANKRATZ VERNON S.¹,LIEBER MICHAEL M.¹,BLUTE MICHAEL L.¹,ZINCKE HORST¹,SEELIG STEVEN A.¹,JENKINS ROBERT B.¹,O’KANE DENNIS J.¹

Affiliation:

1. From the Departments of Laboratory Medicine and Pathology, Urology and Biostatistics, Mayo Clinic and Foundation, Rochester, Minnesota, and Vysis, Inc., Downers Grove, Illinois

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference46 articles.

1. Bladder cancer: state-of-the-art care;Droller;Ca: Cancer J Clin,1998

2. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors;Fitzgerald;J Natl Cancer Inst,1995

3. A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer;Schmetter;J Urol,1997

4. Multicenter trial of the quantitative BTA-TRAK assay in the detectin of bladder cancer;Thomas;Clin Chem,1999

5. The clinical value of urinary cytology: 12 years of experience with 615 patients;Maier;J Clin Pathol,1995

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining longitudinal markers of bladder cancer recurrence through a semiautonomous machine learning system for quantifying specimen atypia from urine cytology;Cancer Cytopathology;2023-06-26

2. Examining Longitudinal Markers of Bladder Cancer Recurrence Through a Semi-Autonomous Machine Learning System for Quantifying Specimen Atypia from Urine Cytology;2023-03-05

3. UroVysionTM Fluorescence In Situ Hybridization in Urological Cancers: A Narrative Review and Future Perspectives;Cancers;2022-11-03

4. Fluorescence in situ hybridization (FISH) to predict the efficacy of Bacillus Calmette-Guérin perfusion in bladder cancer;Translational Cancer Research;2022-10

5. Comparison of the clinical usefulness of different urinary tests for the initial detection of bladder cancer: a systematic review;Current Urology;2021-03